← back to search

K. Coote

Novartis (Switzerland) · CH
Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research focused on CRISPR and Induced pluripotent stem cell, with related work in Bystander effect, RNA, Cystic fibrosis. Notable publications include 'Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope', 'A multimodal iPSC platform for cystic fibrosis drug testing', and 'A streamlined base editor engineering strategy to reduce bystander editing'.
h-index
citations
158
works
3
NIH funding
primary concept
email

Recent publications

A streamlined base editor engineering strategy to reduce bystander editing
Nature Communications 2025cited by 6position: middledoi
A multimodal iPSC platform for cystic fibrosis drug testing
Nature Communications 2022cited by 43position: middledoi
Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope
Nature Communications 2020cited by 109position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

H. Valley · Children's Healthcare of Atlanta3 papers (2020–2025) · 2 papers (2022–2025)Martin Mense · Berlin Institute of Health at Charité - Universitätsmedizin Berlin2 papers (2020–2025) · 1 papers (2020–2020)Mary Lou Beermann · Boston University1 papers (2022–2022)Yueying Cao · University of Massachusetts Chan Medical School1 papers (2020–2020)Jake A. Le Suer · Boston University1 papers (2022–2022) · 1 papers (2025–2025)Samuele G. Marro · Allen Institute for Brain Science1 papers (2025–2025) · 1 papers (2025–2025) · 1 papers (2025–2025) · 1 papers (2025–2025)John E. Mahoney · Cystic Fibrosis Foundation1 papers (2022–2022)Andrew Berical · Boston University1 papers (2022–2022)Anton P. McCaffrey · Medizinische Hochschule Hannover1 papers (2020–2020)Paul McNally · Royal College of Surgeons in Ireland1 papers (2022–2022)Jordana M. Henderson · San Diego State University1 papers (2020–2020)Luke H. Rhym · Massachusetts Institute of Technology1 papers (2020–2020)Daniel G. Anderson · Massachusetts Institute of Technology1 papers (2020–2020)Gregory A. Newby · Elon University1 papers (2020–2020)